Search

Sixth-year graduate student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper accepted for publication in the January 28, 2012 issue of Science.

… Wednesday, August 15, 2012 Sixth-year student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper “Crystal Structure of the Human Two-Pore Domain Potassium Channel K2P1,” published in the journal Science on January 26, 2012 . The study, which revealed the three-dimensional shape

Memorial Sloan Kettering Cancer Center today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.

… Friday, March 14, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. The new building has been thoughtfully designed to meet

MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.

… Friday, October 1, 2021 Memorial Sloan Kettering Cancer Center pediatric oncologist Julia Glade Bender recalls very clearly the event that sparked her interest in improving care for adolescents and young adults with cancer. She was treating children with cancer at another New York City medical center

For the past 27 years the MSK Facilities Team has created a beautiful holiday wonderland to spread cheer to staff and patients alike. This year, Santa’s MSK helpers came to the rescue in more ways than one.

… Monday, December 21, 2020 VIDEO | 02:06 2020 Holiday Hallway Montage Take a Tour of MSK's Holiday Hallway Video Details For the past 27 years, if you strolled into Memorial Sloan Kettering’s basement corridor during December, you would find the MSK Facilities Team, including carpenters, plumbers, locksmiths

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.

… Saturday, June 3, 2017 Summary Previous therapies targeting specific genetic mutations have had mixed results across different cancer types. A new drug, larotrectinib, appears to work in all cancers with a mutation called a TRK fusion. These results are potentially practice changing. The success of precision

Learn how pre-health students at Hunter College can get a feel for a career at MSK.

… Tuesday, July 13, 2021 Asha Ewrse thought she wanted to be an English major. But as she explored future career options, she realized something. “Over time, my focus became less about books themselves and more about the people — the minds and souls that serve as the foundation of any art form,” says Ms

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.

… Friday, January 17, 2025 Anh Le had begun her second year of medical school in Chicago, in 2018, when she suddenly faced her own health emergency: a rare, deadly form of cervical cancer called glassy cell carcinoma. The diagnosis threw her life — and promising career — into turmoil. It also set her on

Learn about how first-year student get oriented to the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).

… Friday, September 10, 2021 Whether you’re in grade school or graduate school, late summer means it’s back to school season. It comes with the anticipation of exciting opportunities to set new goals, learn new things, and meet new people. This is not lost on the 18 first-year students who recently began

Learn how to manage menopause symptoms if you have breast cancer

… Friday, October 28, 2016 Summary The menopause symptoms that can sometimes happen as a result of breast cancer treatment are an unwelcome side effect. Memorial Sloan Kettering medical oncologist Shari Goldfarb shares her recommendations for how women can find relief. Highlights Women with breast cancer

Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.

… Monday, August 3, 2020 Summary A large international study led by researchers at Memorial Sloan Kettering has immediate clinical relevance for risk assessment and treatment of people with myelodysplastic syndrome and acute myeloid leukemia. Considered the “guardian of the genome,” TP53 is the most commonly